SUPPLEMENTARY MATERIAL
. Hazard ratio for myocardial infarction in subgroup and pooled by multivariate meta-analysis. Note: Weights are from random-effect meta-analysis and inversely proportional to the variance of the estimated hazard ratios (therefore proportional to the number of events contributing the hazard ratios).. Data is presented as hazard ratio and their 95% CI. Analyses were adjusted for age, smoking status, SBP, total cholesterol. Estimates were pooled by random effects meta-analysis within each subgroup. Figure 3 . Hazard ratio for stroke in NAFLD patients without a NASH records. Note: Weights are from random-effect meta-analysis and inversely proportional to the variance of the estimated hazard ratios (therefore proportional to the number of events contributing the hazard ratios).. Data is presented as hazard ratio and their 95% CI. Analyses were progressively adjusted for age, smoking status, type 2 diabetes, SBP, total cholesterol, statin use and hypertension. Note: it was only possible to run this analysis in the SIDIAP and THIN databases as separate codes are available for NAFLD and NASH. Figure 4 . Hazard ratio for stroke in NAFLD patients without a NASH records by subgroup and pooled across databases by multivariate meta-analysis. Note: Weights are from random-effect meta-analysis and inversely proportional to the variance of the estimated hazard ratios (therefore proportional to the number of events contributing the hazard ratios).. Data is presented as hazard ratio and their 95% CI. Analyses adjusted for age, smoking status, SBP and total cholesterol. Estimates were pooled by random effects meta-analysis within each subgroup. Figure 5 . Sensitivity analyses -Hazard ratio for myocardial infarction with in NAFLD patients including patients with less than 6 months of medical history prior and follow-up post index date, or who had a history of stroke or MI. Note: Weights are from random-effect meta-analysis and inversely proportional to the variance of the estimated hazard ratios (therefore proportional to the number of events contributing the hazard ratios).. Data is presented as hazard ratio and their 95% CI. Analyses were progressively adjusted for age, smoking status, type 2 diabetes, SBP, total cholesterol, statin use and hypertension. Figure 6 . Sensitivity analyses for hazard ratio for stroke in patients with NAFLD including patients with less than 6 months of medical history prior and follow-up post index date, or who had a history of stroke or MI. Note: Weights are from random-effect meta-analysis and inversely proportional to the variance of the estimated hazard ratios (therefore proportional to the number of events contributing the hazard ratios).. Data is presented as hazard ratio and their 95% CI. Analyses were progressively adjusted for age, smoking status, type 2 diabetes, SBP, total cholesterol, statin use and hypertension. Figure 7 . Association of NAFLD/NASH with myocardial infarction excluding patients with less than 6 months follow-up post index date (excluding events happening in the first 6 months after index date). Note: Weights are from random-effect meta-analysis and inversely proportional to the variance of the estimated hazard ratios (therefore proportional to the number of events contributing the hazard ratios).
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Data is presented as hazard ratio and their 95% CI. Analyses were progressively adjusted for age, smoking status, type 2 diabetes, SBP, total cholesterol, statin use and hypertension. Data for age and smoking (total population data set) was available for 59,881 (patients without NAFLD n=58,970; patients with NAFLD n=911). A subset* of participants have full data available for age, smoking, type 2 diabetes, SBP, total cholesterol, statin use and hypertension, therefore the analyses were restricted to 32,481 (Non NAFLD patients n=31,829; patients with NAFLD n=652). Note that the percentage of current smokers is estimated after imputation of patients with missing smoking status as non-current smokers.
